We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

63 hedge funds and large institutions have $9.83M invested in Cue Health Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,250% more call options, than puts

Call options by funds: $87K | Put options by funds: $2K

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

13% less funds holding

Funds holding: 7263 (-9)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

66% less capital invested

Capital invested by funds: $28.6M → $9.83M (-$18.8M)

Holders
63
Holders Change
-9
Holders Change %
-12.5%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
7
Increased
9
Reduced
21
Closed
14
Calls
$87K
Puts
$2K
Net Calls
+$85K
Net Calls Change
-$142K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
+$33 +98 New

HLTH Hedge Fund Activity: Q4 2023 in Review

63 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q4 2023, worth a combined $9.83M — down 66% from $28.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of HLTH and 7 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 9 added.

The largest buyer was Goldman Sachs, adding an estimated $1.29M. The largest seller was Johnson & Johnson, exiting entirely with an estimated $2.45M sold.

  • 63 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q4 2023, down from 72 in Q3 2023.
  • Funds reported $9.83M of Cue Health Inc. Common Stock stock for Q4 2023, down 66% quarter-over-quarter.
  • 7 funds opened new Cue Health Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -7 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q4 2023 was Goldman Sachs, an estimated $1.29M added.
  • The largest Cue Health Inc. Common Stock seller in Q4 2023 was Johnson & Johnson, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2023.